154 related articles for article (PubMed ID: 9834102)
41. [Flt3 ligand in recovering the function of the splenic dendritic cells and the immune system in mice with multiple organ dysfunction syndrome].
Tian G; Lu JY; Wang HW; Liu Q; Yang Y
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Jan; 20(1):45-8. PubMed ID: 18199402
[TBL] [Abstract][Full Text] [Related]
42. Immunomodulatory gene therapy with interleukin 12 and 4-1BB ligand: long- term remission of liver metastases in a mouse model.
Martinet O; Ermekova V; Qiao JQ; Sauter B; Mandeli J; Chen L; Chen SH
J Natl Cancer Inst; 2000 Jun; 92(11):931-6. PubMed ID: 10841829
[TBL] [Abstract][Full Text] [Related]
43. Transduction of dendritic cells with Bcl-xL increases their resistance to prostate cancer-induced apoptosis and antitumor effect in mice.
Pirtskhalaishvili G; Shurin GV; Gambotto A; Esche C; Wahl M; Yurkovetsky ZR; Robbins PD; Shurin MR
J Immunol; 2000 Aug; 165(4):1956-64. PubMed ID: 10925278
[TBL] [Abstract][Full Text] [Related]
44. Regulation of dendritic cell function by NK cells: mechanisms underlying the synergism in the combination therapy of IL-12 and 4-1BB activation.
Pan PY; Gu P; Li Q; Xu D; Weber K; Chen SH
J Immunol; 2004 Apr; 172(8):4779-89. PubMed ID: 15067054
[TBL] [Abstract][Full Text] [Related]
45. Immunomodulating and antitumor activities of a synthetic lauroyltripeptide (RP 56 142).
Fizames C; Poirier J; Floc'h F
J Biol Response Mod; 1989 Aug; 8(4):397-408. PubMed ID: 2754438
[TBL] [Abstract][Full Text] [Related]
46. In vivo antitumor activity of a recombinant IL-7/HGFbeta hybrid cytokine in mice.
Lai L; Jin J; Goldschneider I
Cancer Res; 2011 Jan; 71(1):61-7. PubMed ID: 21084268
[TBL] [Abstract][Full Text] [Related]
47. Antitumor mechanisms of Z-100, an immunomodulatory arabinomannan extracted from Mycobacterium tuberculosis: the importance of lymphocytes infiltrated into tumor sites.
Sasaki H; Schmitt D; Hayashi Y; Pollard RB; Suzuki F
Nat Immun; 1993; 12(2):104-12. PubMed ID: 8318815
[TBL] [Abstract][Full Text] [Related]
48. [Immunological effects of locoregional immunochemotherapy for liver metastases of gastric cancer].
Sugiyama Y; Kato M; Takao H; Kida H; Kunieda K; Umemoto T; Miya K; Azuma S; Furuta T; Saji S
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1461-4. PubMed ID: 8373205
[TBL] [Abstract][Full Text] [Related]
49. Antitumor and antimetastatic activity of interleukin 12 against murine tumors.
Brunda MJ; Luistro L; Warrier RR; Wright RB; Hubbard BR; Murphy M; Wolf SF; Gately MK
J Exp Med; 1993 Oct; 178(4):1223-30. PubMed ID: 8104230
[TBL] [Abstract][Full Text] [Related]
50. Differential antitumor effect of interleukin-12 family cytokines on orthotopic hepatocellular carcinoma.
Lo CH; Chang CM; Tang SW; Pan WY; Fang CC; Chen Y; Wu PY; Chen KY; Ma HI; Xiao X; Tao MH
J Gene Med; 2010 May; 12(5):423-34. PubMed ID: 20440753
[TBL] [Abstract][Full Text] [Related]
51. Intrahepatic lymphocyte analyses and assessment of the effects of levamisole in murine hepatic metastasis model.
Endo S; Kinoshita J; Yoshimatsu K; Kato H; Haga S; Kajiwara T
Anticancer Res; 1998; 18(2A):907-10. PubMed ID: 9615739
[TBL] [Abstract][Full Text] [Related]
52. Conditional ablation of NKp46+ cells using a novel Ncr1(greenCre) mouse strain: NK cells are essential for protection against pulmonary B16 metastases.
Merzoug LB; Marie S; Satoh-Takayama N; Lesjean S; Albanesi M; Luche H; Fehling HJ; Di Santo JP; Vosshenrich CA
Eur J Immunol; 2014 Nov; 44(11):3380-91. PubMed ID: 25142413
[TBL] [Abstract][Full Text] [Related]
53. Decreased mortality of Norman murine sarcoma in mice treated with the immunomodulator, Acemannan.
Peng SY; Norman J; Curtin G; Corrier D; McDaniel HR; Busbee D
Mol Biother; 1991 Jun; 3(2):79-87. PubMed ID: 1910624
[TBL] [Abstract][Full Text] [Related]
54. Antitumor mechanisms of attenuated Salmonella typhimurium containing the gene for human interleukin-2: a novel antitumor agent?
Saltzman DA; Katsanis E; Heise CP; Hasz DE; Vigdorovich V; Kelly SM; Curtiss R; Leonard AS; Anderson PM
J Pediatr Surg; 1997 Feb; 32(2):301-6. PubMed ID: 9044141
[TBL] [Abstract][Full Text] [Related]
55. Protective effect of Flt3L on organ structure during advanced multiorgan dysfunction syndrome in mice.
Tian G; Lu J; Guo H; Liu Q; Wang H
Mol Med Rep; 2015 Jun; 11(6):4135-41. PubMed ID: 25672780
[TBL] [Abstract][Full Text] [Related]
56. Adjuvant effect of a Flt3 ligand (FL) gene-transduced xenogeneic cell line in a murine colon cancer model.
Kim EM; Sivanandham M; Stavropoulos CI; Wallack MK
J Surg Res; 2002 Nov; 108(1):148-56. PubMed ID: 12443727
[TBL] [Abstract][Full Text] [Related]
57. Flt3 ligand enhances anti-tumor effects of antibody therapeutics.
Maruyama K; Selmani Z; Ishii H; Tai S; Cheng J; Akimoto S; Watanabe M; Yamaguchi K
Int Immunopharmacol; 2012 Mar; 12(3):481-6. PubMed ID: 22245429
[TBL] [Abstract][Full Text] [Related]
58. Characterization of the antitumor activity of a polyantigenic immunomodulator (PAI): II--Involvement of NK cells and adoptive immunotherapy.
Orraca ZM; Ríos-Olivares E; Carrasco-Canales JA; Aquino E; Marchand AM; Colón JI
Bol Asoc Med P R; 1989 Jul; 81(7):254-8. PubMed ID: 2775402
[TBL] [Abstract][Full Text] [Related]
59. Antitumor effects of Flt3 ligand in transplanted murine tumor models.
Averbook BJ; Schuh JL; Papay R; Maliszewski C
J Immunother; 2002; 25(1):27-35. PubMed ID: 11924908
[TBL] [Abstract][Full Text] [Related]
60. Enhanced antitumoral effectiveness of idiotype vaccination induced by the administration of Flt3 ligand combined with interleukin 2 against a murine myeloma.
Zeis M; Zunkel T; Steinmann J; Schmitz N; Uharek L
Br J Haematol; 2002 Apr; 117(1):93-102. PubMed ID: 11918538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
